Daniel A. Harki
- Virology top 2%
- HIV Research and Treatment 12
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 9
- RNA and protein synthesis mechanisms 8
- Natural product bioactivities and synthesis 7
- CRISPR and Genetic Engineering 7
- Advanced biosensing and bioanalysis techniques 7
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 11
- Cancer Research top 10%
- Environmental Chemistry top 5%
-
- Viral Infections and Immunology Research 10
- Co-authors
- John C. WidenKay M. BrummondPaul JacksonReuben S. HarrisMargaret E. OlsonPetia P. SimeonovaMichael I. LusterBlake R. Peterson
- Journals
- Journal of Medicinal Chemistry (8 papers)ACS Medicinal Chemistry Letters (6 papers)ACS Chemical Biology (5 papers)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Daniel A. Harki
73 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Virology 239
- Molecular Biology 1.6k
- Infectious Diseases 371
- Cancer Research 255
- Environmental Chemistry 155
Countries citing papers authored by Daniel A. Harki
This map shows the geographic impact of Daniel A. Harki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Harki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Harki more than expected).
Fields of papers citing papers by Daniel A. Harki
This network shows the impact of papers produced by Daniel A. Harki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Harki. The network helps show where Daniel A. Harki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel A. Harki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 20 | |
| 6 | 2023 | 25 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 27 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 19 | |
| 17 | 2018 | 20 | |
| 18 | 2018 | 36 | |
| 19 | 2018 | 20 | |
| 20 | 2016 | 30 |
About Daniel A. Harki
Daniel A. Harki is a scholar working on Virology, Infectious Diseases and Molecular Biology, having authored 77 papers that have together received 2.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers), Viral Infections and Immunology Research (10 papers), Protein Degradation and Inhibitors (9 papers), RNA and protein synthesis mechanisms (8 papers), Natural product bioactivities and synthesis (7 papers), CRISPR and Genetic Engineering (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). The work is most often cited by research in Virology (239 citations), Molecular Biology (1.6k citations) and Infectious Diseases (371 citations). Daniel A. Harki has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include John C. Widen, Kay M. Brummond, Paul Jackson, Reuben S. Harris, Margaret E. Olson, Petia P. Simeonova, Michael I. Luster, Blake R. Peterson, Peter B. Dervan and Aaron Kempema. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, ACS Chemical Biology, Organic Letters and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.